A NICU study evaluating Masimo SET® pulse oximetry on hospitalized newborns found no clinically significant differences in ...
Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Irvine-based medical device maker Masimo announces data from a study showing that its pulse oximetry technology accurately ...
Releases Study on the Positive Economic Impacts of Pacifico Mexinol Project in Northern Sinaloa. The study, among other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results